Multimodal therapy may hold key to treating aggressive childhood cancer
Research led by scientists at Children’s Cancer Institute and published this week in the international journal, Clinical Cancer Research, has found a combination of therapies that appears to be highly effective against high-risk neuroblastoma and other forms of aggressive childhood cancer. Up to half of all cases of neuroblastoma newly diagnosed in children are ‘high-risk’,…